IMPACT [gngm]
tibolone [phsu, strd]
Hormone Therapy [topp]
C-reactive protein [aapp, imft]
tumor necrosis factor [aapp, imft]
Hepatocyte Growth Factor [aapp, bacs]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
investigate [ftcn]
tibolone [phsu, strd]
hormone treatment [topp]
C-reactive protein [aapp, imft]
tumor necrosis factor [aapp, imft]
Hepatocyte Growth Factor [aapp, bacs]
Independent [idcn]
Marker [clna]
Cardiovascular disease [dsyn]
Design [acty]
Five [qnco]
Normotensive [fndg]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Systemic [ftcn]
Disease, Cardiac [dsyn]
Attended [ftcn]
Marmara [euka]
University [mnob, orgt]
Menopause [phsf]
Outpatient Clinic [hcro, mnob]
included [ftcn]
Study [mnob]
Women [popg]
Assigned [ftcn]
Group [idcn]
Women [popg]
Accepted [qlco]
Hormone replacement therapy [topp]
randomized [resa]
Group [idcn]
Group 1 [inpr]
Received [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Acetate [orch, phsu]
Group 2 [inpr]
Received [qlco]
tibolone [phsu, strd]
Group 3 [inpr]
Control Group [grup]
Women [popg]
Hormone replacement therapy [topp]
Serum sample [bdsu]
Measured [qlco]
Highly [qlco]
Specific [qlco]
C-reactive protein [aapp, imft]
tumor necrosis factor [aapp, imft]
Hepatocyte Growth Factor [aapp, bacs]
treatment [ftcn]
months [tmco]
therapy [ftcn]
Values [qlco]
End [spco]
baseline [bodm]
Compared [acty]
C-reactive protein [aapp, imft]
Decrease [qlco]
tumor necrosis factor [aapp, imft]
End [spco]
treatment [ftcn]
statistically significant [qnco]
Hormone Therapy [topp]
tibolone [phsu, strd]
Group [idcn]
Decrease [qlco]
Hepatocyte Growth Factor [aapp, bacs]
tibolone [phsu, strd]
Group [idcn]
Conclusions [idcn]
IMPACT [gngm]
tibolone [phsu, strd]
Hormone Therapy [topp]
Inflammatory [ftcn]
Marker [clna]
APPEAR [qlco]
Cardiovascular Diseases [dsyn]
findings [ftcn]
Evaluated [ftcn]
Large [qnco]
Clinical Trials [resa]
